Chronic, symptomatic Hyperuricemia

Drug	Drug Name	Drug Description
DB04854	Febuxostat	A xanthine oxidase inhibitor used for the management of chronic hyperuricemia in adults with gout who have an inadequate response or intolerance to allopurinol.

Drug	Drug Name	Target	Type
DB04854	Febuxostat	Serum albumin	carrier
DB04854	Febuxostat	Xanthine dehydrogenase/oxidase	target
DB04854	Febuxostat	UDP-glucuronosyltransferase 1-1	enzyme
DB04854	Febuxostat	UDP-glucuronosyltransferase 1-3	enzyme
DB04854	Febuxostat	UDP-glucuronosyltransferase 1-9	enzyme
DB04854	Febuxostat	UDP-glucuronosyltransferase 2B7	enzyme
DB04854	Febuxostat	Cytochrome P450 1A2	enzyme
DB04854	Febuxostat	Cytochrome P450 2C8	enzyme
DB04854	Febuxostat	Cytochrome P450 2C9	enzyme
DB04854	Febuxostat	ATP-binding cassette sub-family G member 2	transporter

Drug	Drug Name	Phase	Status	Count